van Houte Hans — SEC insider filings
SEC reporting owner CIK 1817217. 45 insider filings on record with FilingPulse; latest filed 2026-11-04.
Transaction summary — filings shown
Covers all 45 filings on record, filed 2021-02-12 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 48 legs across 37 filings — 211,892 shares, $4,768,883 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 118.
- Largest priced transaction: sale of 35,419 shares @ $39.90 ($1,413,218) in Nurix Therapeutics, Inc., filed 2021-02-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | 45 | — | 48 legs · 211,892 sh · $4,768,883 | 118 |
Insider filings — van Houte Hans
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-04 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 3,300 @ $15.38 · Sale (S): 1,469 @ $16.20 | EDGAR |
| 2026-11-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,859 @ $0 · Option exercise (M): 3,573 @ $0 · Sale (S): 2,834 @ $26.28 · Option exercise (M): 3,750 (derivative) @ $0 · Option exercise (M): 2,859 (derivative) @ $0 · +1 more | EDGAR |
| 2026-08-04 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 1,794 @ $23.89 · Sale (S): 2,967 @ $24.65 | EDGAR |
| 2026-07-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Option exercise (M): 3,572 @ $0 · Sale (S): 2,845 @ $23.38 · Option exercise (M): 3,750 (derivative) @ $0 · Option exercise (M): 2,858 (derivative) @ $0 · +1 more | EDGAR |
| 2026-05-05 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 13,473 @ $16.58 · Sale (S): 582 @ $17.18 | EDGAR |
| 2026-04-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 2,388 @ $16.65 · Option exercise (M): 2,000 (derivative) @ $0 · Option exercise (M): 3,750 (derivative) @ $0 · +1 more | EDGAR |
| 2026-02-10 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 93,750 (derivative) @ $0 · Grant/award (A): 42,875 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,887 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,859 @ $0 · Sale (S): 3,588 @ $16.58 · Sale (S): 73 @ $17.37 · +4 more | EDGAR |
| 2025-11-03 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 6,284 @ $12.56 | EDGAR |
| 2025-10-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 3,130 @ $12.80 · Option exercise (M): 2,886 (derivative) @ $0 · +3 more | EDGAR |
| 2025-08-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 5,402 @ $11.03 | EDGAR |
| 2025-07-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 4,304 @ $12.01 · Option exercise (M): 2,886 (derivative) @ $0 · +3 more | EDGAR |
| 2025-05-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 6,198 @ $11.33 | EDGAR |
| 2025-04-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 2,438 @ $11.50 · Option exercise (M): 2,886 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 · +1 more | EDGAR |
| 2025-03-03 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 5,125 @ $14.40 · Sale (S): 700 @ $15.13 | EDGAR |
| 2025-02-13 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 75,000 (derivative) @ $0 · Grant/award (A): 34,300 (derivative) @ $0 | EDGAR |
| 2025-01-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 2,557 @ $19.81 · Sale (S): 254 @ $20.33 · Option exercise (M): 2,886 (derivative) @ $0 · +2 more | EDGAR |
| 2024-11-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 3,546 @ $24.28 | EDGAR |
| 2024-10-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 2,368 @ $24.30 · Option exercise (M): 2,886 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 · +1 more | EDGAR |
| 2024-08-26 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 20,000 @ $25.22 | EDGAR |
| 2024-08-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 3,377 @ $21.43 · Sale (S): 100 @ $22.22 | EDGAR |
| 2024-07-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 2,490 @ $20.67 · Option exercise (M): 2,886 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 · +1 more | EDGAR |
| 2024-06-20 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 20,000 @ $20.01 | EDGAR |
| 2024-05-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 3,499 @ $12.83 | EDGAR |
| 2024-04-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 1,387 @ $12.04 · Option exercise (M): 2,886 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 6,812 @ $10.02 | EDGAR |
| 2024-02-15 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-01-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 1,671 @ $7.99 · Option exercise (M): 2,886 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2023-12-21 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 3,541 @ $10.00 | EDGAR |
| 2023-12-20 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 10,906 @ $10.00 | EDGAR |
| 2023-11-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 1,080 @ $5.20 · Option exercise (M): 2,886 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2023-08-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 1,245 @ $9.65 · Option exercise (M): 2,886 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,886 @ $0 · Sale (S): 721 @ $9.88 · Option exercise (M): 2,886 (derivative) @ $0 | EDGAR |
| 2023-02-15 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 88,900 (derivative) @ $0 · Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2023-02-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,886 @ $0 · Sale (S): 924 @ $11.78 · Option exercise (M): 2,886 (derivative) @ $0 | EDGAR |
| 2022-11-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,886 @ $0 · Sale (S): 739 @ $12.88 · Option exercise (M): 2,886 (derivative) @ $0 | EDGAR |
| 2022-08-10 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2022-08-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,886 @ $0 · Sale (S): 752 @ $15.67 · Option exercise (M): 2,886 (derivative) @ $0 | EDGAR |
| 2022-06-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 68,333 @ $0.84 · Option exercise (M): 68,333 (derivative) @ $0 | EDGAR |
| 2022-05-03 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,886 @ $0 · Sale (S): 697 @ $11.75 · Option exercise (M): 2,886 (derivative) @ $0 | EDGAR |
| 2022-01-21 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 103,894 (derivative) @ $0 · Grant/award (A): 46,177 (derivative) @ $0 | EDGAR |
| 2021-02-25 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 20,393 @ $1.20 · Option exercise (M): 13,197 @ $1.86 · Option exercise (M): 1,829 @ $7.26 · Sale (S): 35,419 @ $39.90 · Option exercise (M): 20,393 (derivative) @ $0 · Option exercise (M): 13,197 (derivative) @ $0 · +1 more | EDGAR |
| 2021-02-23 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,417 @ $0.84 · Option exercise (M): 3,913 @ $1.20 · Sale (S): 5,330 @ $39.93 · Option exercise (M): 1,417 (derivative) @ $0 · Option exercise (M): 3,913 (derivative) @ $0 | EDGAR |
| 2021-02-22 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 13,583 @ $0.84 · Sale (S): 3,140 @ $34.24 · Sale (S): 3,652 @ $35.10 · Sale (S): 5,725 @ $36.00 · Sale (S): 666 @ $36.91 · Sale (S): 400 @ $38.05 · +1 more | EDGAR |
| 2021-02-12 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-02-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1817217 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs